As of the latest SEC filings, Cogent Biosciences, Inc. (COGT) is held by 341 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $188,888,327.85 in market value, representing 0.01% of its portfolio.
Funds holding Cogent Biosciences, Inc. (COGT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- COGT
- CIK:
- 0001622229
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $188,888,327.85 | 4,907,465 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.08% | $136,844,035.86 | 3,555,314 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.19% | $134,532,672.87 | 3,495,263 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 1.60% | $99,456,000.00 | 2,560,000 | Feb 28, 2026 | Apr 24, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.22% | $90,378,407.49 | 2,348,101 | Mar 31, 2026 | May 28, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 1.07% | $89,802,729.03 | 2,509,157 | Apr 30, 2026 | Jun 26, 2026 |
|
VISVX
VANGUARD SMALL-CAP VALUE INDEX FUND
|
ETF | Vanguard | 0.14% | $87,142,668.66 | 2,264,034 | Mar 31, 2026 | May 28, 2026 |
|
FOTEX
Fidelity OTC Portfolio
|
MF | Fidelity | 0.17% | $67,056,144.00 | 1,873,600 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.08% | $65,895,688.29 | 1,712,021 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 1.23% | $65,710,656.90 | 1,691,394 | Feb 28, 2026 | Apr 24, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 3.45% | $65,668,136.22 | 1,834,818 | Apr 30, 2026 | Jun 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.16% | $50,638,734.15 | 1,414,885 | Apr 30, 2026 | Jun 26, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.02% | $50,607,097.80 | 1,302,628 | Feb 28, 2026 | Apr 24, 2026 |
|
LGLQX
Lord Abbett Growth Leaders Fund
|
MF | Independent / Boutique | 0.60% | $45,417,116.31 | 1,268,989 | Apr 30, 2026 | Jun 29, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 1.04% | $44,712,268.05 | 1,249,295 | Apr 30, 2026 | Jun 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.35% | $42,265,869.00 | 1,098,100 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.48% | $38,851,652.04 | 1,009,396 | Mar 31, 2026 | May 28, 2026 |
|
FCDTX
Fidelity Stock Selector Small Cap Fund
|
MF | Fidelity | 0.56% | $38,845,535.46 | 1,085,374 | Apr 30, 2026 | Jun 26, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.29% | $37,358,817.39 | 970,611 | Mar 31, 2026 | May 28, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 1.19% | $34,358,400.00 | 960,000 | Apr 30, 2026 | Jun 26, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.39% | $32,035,073.04 | 832,296 | Mar 31, 2026 | May 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.49% | $31,873,278.15 | 820,419 | Feb 27, 2026 | Apr 24, 2026 |
|
FBAQX
Fidelity Balanced Fund
|
MF | Fidelity | 0.05% | $31,340,023.05 | 806,693 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.08% | $31,117,645.65 | 800,969 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.14% | $28,985,285.70 | 746,082 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)